JP2011520991A5 - - Google Patents

Download PDF

Info

Publication number
JP2011520991A5
JP2011520991A5 JP2011510782A JP2011510782A JP2011520991A5 JP 2011520991 A5 JP2011520991 A5 JP 2011520991A5 JP 2011510782 A JP2011510782 A JP 2011510782A JP 2011510782 A JP2011510782 A JP 2011510782A JP 2011520991 A5 JP2011520991 A5 JP 2011520991A5
Authority
JP
Japan
Prior art keywords
ethoxy
compound
pharmaceutical composition
compound according
pyridazinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011510782A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011520991A (ja
JP5469662B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2009/000663 external-priority patent/WO2009143571A1/en
Publication of JP2011520991A publication Critical patent/JP2011520991A/ja
Publication of JP2011520991A5 publication Critical patent/JP2011520991A5/ja
Application granted granted Critical
Publication of JP5469662B2 publication Critical patent/JP5469662B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011510782A 2008-05-27 2009-05-27 抗ウイルス剤の塩 Expired - Fee Related JP5469662B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5634108P 2008-05-27 2008-05-27
US61/056,341 2008-05-27
PCT/AU2009/000663 WO2009143571A1 (en) 2008-05-27 2009-05-27 Antiviral salts

Publications (3)

Publication Number Publication Date
JP2011520991A JP2011520991A (ja) 2011-07-21
JP2011520991A5 true JP2011520991A5 (https=) 2012-07-05
JP5469662B2 JP5469662B2 (ja) 2014-04-16

Family

ID=41376478

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011510782A Expired - Fee Related JP5469662B2 (ja) 2008-05-27 2009-05-27 抗ウイルス剤の塩

Country Status (14)

Country Link
US (2) US8580791B2 (https=)
EP (1) EP2297141B1 (https=)
JP (1) JP5469662B2 (https=)
KR (1) KR20110019759A (https=)
CN (1) CN102046621B (https=)
AU (1) AU2009253738B2 (https=)
BR (1) BRPI0912038A2 (https=)
CA (1) CA2725618C (https=)
CO (1) CO6280534A2 (https=)
EA (1) EA020455B1 (https=)
MX (1) MX2010013019A (https=)
NZ (1) NZ590286A (https=)
WO (1) WO2009143571A1 (https=)
ZA (1) ZA201009284B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ603040A (en) * 2010-04-15 2015-03-27 Biota Scient Management Compound for treatment of respiratory condition or disease
EP2585067B1 (en) 2010-06-25 2017-08-09 Biota Scientific Management Pty Ltd Compound for the treatment of enteroviruses
CN102617462B (zh) * 2012-02-28 2014-02-12 南京大学 特异性抑制肌肉微小核糖核酸的化合物及其合成方法和应用
EA201692549A1 (ru) * 2014-06-20 2017-08-31 Эвайраджен Терепьютикс, Инк. Безводная кристаллическая форма свободного основания 6-{2-[1-(6-метил-3-пиридазинил)-4-пиперидинил]этокси}-3-этокси-1,2-бензизоксазола
US20250281519A1 (en) * 2021-05-05 2025-09-11 Emory University Nucleotide and nucleoside therapeutic compositions, combinations and uses related thereto
WO2024192151A2 (en) * 2023-03-13 2024-09-19 Altesa BioSciences, Inc. Method of dosing vapendavir to treat enterovirus infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170387B (it) 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB2162522B (en) 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB9026998D0 (en) 1990-12-12 1991-01-30 Glaxo Group Ltd Medicaments
US5514778A (en) * 1993-07-01 1996-05-07 Eli Lilly And Company Anti-picornaviral agents
US5693661A (en) * 1995-06-07 1997-12-02 Eli Lilly And Company Anti-viral compounds
US5545653A (en) * 1995-06-07 1996-08-13 Eli Lilly And Company Anti-viral compounds
US5891874A (en) * 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds
AU6031898A (en) * 1997-01-22 1998-08-07 Eli Lilly And Company Anti-viral compounds
CA2293508A1 (en) * 1997-06-04 1998-12-10 Louis Nickolaus Jungheim Anti-viral compounds
CZ289425B6 (cs) * 1998-05-20 2002-01-16 Eli Lilly And Company Imidazo[1,2-a] pyridinové sloučeniny, jejich pouľití a farmaceutický přípravek s jejich obsahem
US6358971B1 (en) * 1998-05-20 2002-03-19 Eli Lilly And Company Anti-viral compounds
AUPR213700A0 (en) 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents

Similar Documents

Publication Publication Date Title
JP2011520991A5 (https=)
UA90545C2 (ru) Твердая фармацевтическая лекарственная форма для перорального введения с быстрым высвобождением ингибитора фактора ха свертывания крови
WO2007127635A3 (en) Diketo-piperazine and piperidine derivatives as antiviral agents
NZ593712A (en) Intermediates for synthesising nucleoside aryl phosphoramidates
JP2008538115A5 (https=)
JP2011507977A5 (https=)
WO2009080705A3 (en) Bis-thiazole derivatives, process for their preparation and their use as medicaments
MX2008013212A (es) 4-anilinquinolina-3-carboxamidas como inhibidores de la cinsa csf-1r.
JP2009506014A5 (https=)
NZ596820A (en) Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
JP2010518061A5 (https=)
JP2014503593A5 (https=)
WO2008009639A2 (en) New indications for direct thrombin inhibitors
NZ596154A (en) Cyclic compound having substituted phenyl group
CN115315423A (zh) 取代芳基类化合物
JP2008534453A5 (https=)
JP2011527687A5 (https=)
NO20044571L (no) Isokinolinderivater
JP2010521516A5 (https=)
SG179031A1 (en) Hsl inhibitors useful in the treatment of diabetes
JP2012508256A5 (https=)
JP2009513604A5 (https=)
JP2010500284A5 (https=)
JP2011519873A5 (https=)
JP2012504584A5 (https=)